| JYSZ2100533 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | License Renew | 2021-12-16 | | | | | view |
| JYSB2400153 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-07-16 | | | | | view |
| JYSB2400036 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-02-28 | | | | | view |
| JYSB2200191 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2022-10-10 | | | | | view |
| JYSB2200155 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2022-08-16 | | | | | view |
| JYSB2200104 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2022-06-23 | | | | | view |
| JYSB2000563 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2020-11-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-11-20 | view |
| JYSB2000530 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2020-10-26 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-11-09 | view |
| JYSB2000339 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2020-07-08 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2021-09-13 | view |
| JYSB2000321 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2020-06-29 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-07-01 | view |
| JYSB1900089 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2019-04-30 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2019-08-30 | view |
| JYSB1800171 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2018-08-22 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2018-10-29 | view |
| JYSB1800170 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2018-08-22 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2018-10-29 | view |
| JYSB1600046 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2016-04-05 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2016-10-10 | view |
| JYSB1600045 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2016-04-05 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2016-10-10 | view |
| JYSB1500428 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2015-12-24 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2016-04-11 | view |
| JYSB1500427 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2015-12-24 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2016-04-11 | view |
| JYSB1500238 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2015-09-29 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2015-12-11 | view |
| JYSB1500237 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2015-09-29 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2015-12-11 | view |
| JYSB1500221 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2015-09-09 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2015-12-04 | view |
